Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.
Stem cell therapies work by promoting endogenous repair; that is, they aid damaged tissue in repairing itself by secreting “paracrine factors,” including proteins and genetic materials. While stem cell therapies can be effective, they are also associated with some risks of both tumor growth and immune rejection. Also, the cells themselves are very fragile, requiring careful storage and a multi-step process of typing and characterization before they can be used.
Ke Cheng, associate professor of molecular biomedical sciences at NC State, associate professor in the joint biomedical engineering program at NC State and UNC, and adjunct associate professor at the UNC Eshelman School of Pharmacy, led a team in developing the synthetic version of a cardiac stem cell that could be used in off-the-shelf applications.
Cheng and his colleagues fabricated a cell-mimicking microparticle (CMMP) from poly (lactic-co-glycolic acid) or PLGA, a biodegradable and biocompatible polymer. The researchers then harvested growth factor proteins from cultured human cardiac stem cells and added them to the PLGA. Finally, they coated the particle with cardiac stem cell membrane.
“We took the cargo and the shell of the stem cell and packaged it into a biodegradable particle,” Cheng says.
When tested in vitro, both the CMMP and cardiac stem cell promoted the growth of cardiac muscle cells. They also tested the CMMP in a mouse model with myocardial infarction, and found that its ability to bind to cardiac tissue and promote growth after a heart attack was comparable to that of cardiac stem cells. Due to its structure, CMMP cannot replicate – reducing the risk of tumor formation.
“The synthetic cells operate much the same way a deactivated vaccine works,” Cheng says. “Their membranes allow them to bypass the immune response, bind to cardiac tissue, release the growth factors and generate repair, but they cannot amplify by themselves. So you get the benefits of stem cell therapy without risks.”
The synthetic stem cells are much more durable than human stem cells, and can tolerate harsh freezing and thawing. They also don’t have to be derived from the patient’s own cells. And the manufacturing process can be used with any type of stem cell.
“We are hoping that this may be a first step toward a truly off-the-shelf stem cell product that would enable people to receive beneficial stem cell therapies when they’re needed, without costly delays,” Cheng says.
[osd_subscribe categories=’stem-cells’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “STEM CELLS”‘]
Receive an email update when we add a new STEM CELLS article.
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Induced Pluripotent Stem Cells (iPSCs) Market Outlook and Forecast 2022 To 2027 with Top Countries Dataon September 23, 2022 at 5:51 am
Sep 23, 2022 (The Expresswire) -- "Induced Pluripotent Stem Cells (iPSCs) Market" valuation is Projected to reach USD 202.9 Mn USD by 2027, From 90 Mn USD ...
- Stem Cell Characterization Kits Market Detailed Analysis of Current Scenario with Growth Forecasts to 2028on September 22, 2022 at 11:25 pm
Stem Cell Characterization Kits Market Research Report is spread across 98 Pages and provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche ...
- Computer simulations visualize how an essential stem cell protein opens wrapped DNAon September 22, 2022 at 7:44 am
A key protein for converting adult stem cells into cells that resemble embryonic stem cells has been visualized in unprecedented detail by an international team of researchers around Hans Schöler and ...
- Maryland Stem Cell Research Fund launches stem cell therapy manufacturing grant programon September 22, 2022 at 5:28 am
The new program from TEDCO's Maryland Stem Cell Research Fund will support stem cell manufacturing throughout the state.
- A Consistent Lack of Sleep Negatively Impacts Immune Stem Cellson September 22, 2022 at 2:13 am
Consistently losing an hour and a half of sleep a night can negatively affect immune cells, potentially increasing the risk of inflammatory disorders and cardiovascular disease.
- A consistent lack of sleep negatively impacts immune stem cells, increasing risk of inflammatory disorders and heart diseaseon September 21, 2022 at 2:15 pm
Sleep exerts lasting effects on hematopoietic stem cell function and diversity. Journal of Experimental Medicine , 2022; 219 (11) DOI: 10.1084/jem.20220081 Cite This Page : ...
- Global Stem Cells Market to Reach $532.29 Million by 2027on September 19, 2022 at 1:28 am
The "Global Stem Cells Market (2022-2027) by Product, Technology, Source, Applications, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ...
- This Blood Stem Cell Research Could Change Medicine of the Futureon September 17, 2022 at 4:26 pm
New discoveries about embryonic blood stem cell creation made independently by biomedical engineers and medical researchers at the University of New South Wales (UNSW) Sydney could one day eliminate ...
- Can Embryonic Blood Stem Cells Change Medicine of the Future?on September 13, 2022 at 3:08 pm
Findings about embryonic blood stem cell creation could one day eliminate the need for blood stem cell donors. The achievements are part of a move in regenerative medicine towards the use of ...
via Bing News